Followers | 817 |
Posts | 31026 |
Boards Moderated | 5 |
Alias Born | 03/22/2016 |
![](https://investorshub.advfn.com/uicon/558887.png?cb=1721046880)
Tuesday, April 16, 2024 3:34:04 PM
Recent RANI News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 10:06:57 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/23/2024 10:05:12 AM
- Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:19:32 PM
- Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:03:53 PM
- Rani Therapeutics to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:09:53 PM
- Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:04:34 PM
- Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:10:21 PM
- Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:06:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 01:05:09 PM
- Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 10:18:12 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM